BeOne Medicines Ltd(MX:6160N)
MX:6160N
BeOne Medicines Ltd stock forecast
BeOne Medicines Ltd (6160N) Stock Forecast & Price Target
0 Followers
6160N Analyst Ratings
Strong Buy
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to BeOne Medicines Ltd in the past 3 months
6160N Stock 12 Month Forecast
Average Price Target
Mex$870.84▲(0.00% Upside)Based on 3 Wall Street analysts offering 12 month price targets for BeOne Medicines Ltd in the last 3 months. The average price target is MXN 870.84 with a high forecast of MXN 1,256.39 and a low forecast of MXN 667.38. The average price target represents a ― change from the last price of ―.
Highest Price TargetHighestMex$1,256Average Price TargetMex$870.84Lowest Price TargetLowestMex$667.38
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | CICC | Mex$631.76→Mex$667.38 | buy | ― | Reiterated | 11/06/26 | ||
| Unknown AnalystNot Ranked | UBS | Mex$665.48→Mex$1,256 | buy | ― | Reiterated | 11/05/26 | ||
| Mark Kong CFA | DBS | Mex$688.76 | buy | ― | Reiterated | 09/28/26 | ||
| Unknown AnalystNot Ranked | Daiwa | Mex$641.26 | buy | ― | Reiterated | 08/12/26 | ||
| Unknown AnalystNot Ranked | BOCOM International Holdings Company | Mex$655.51 | buy | ― | Reiterated | 08/08/26 | ||
| Unknown AnalystNot Ranked | CLSA | Mex$764.05 | buy | ― | Reiterated | 08/06/26 | ||
| David Li | Bank of America Securities | Mex$579.03→Mex$606.65 | buy | ― | Reiterated | 08/06/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | Mex$629.38 | buy | ― | Reiterated | 08/06/26 | ||
| Unknown AnalystNot Ranked | Nomura | Mex$643.02 | buy | ― | Reiterated | 07/24/26 | ||
| Unknown AnalystNot Ranked | Macquarie | Mex$610.38 | buy | ― | Reiterated | 07/13/26 | ||
| Unknown AnalystNot Ranked | HSBC | Mex$535.81 | buy | ― | Reiterated | 07/10/26 | ||
| Unknown AnalystNot Ranked | Huafu Securities | Mex$706.43 | buy | ― | Reiterated | 07/06/26 | ||
| Unknown AnalystNot Ranked | Citi | Mex$645.53 | buy | ― | Reiterated | 06/02/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | Mex$570.01→Mex$555.76 | buy | ― | Reiterated | 05/12/26 | ||
| Unknown AnalystNot Ranked | CMBC International | Mex$662.28 | buy | ― | Reiterated | 05/10/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystCICCNot Ranked | BuyReiteratedMex$631.76→Mex$667.38 | 11/06/26 | ― | ||
| Unknown AnalystUBSNot Ranked | BuyReiteratedMex$665.48→Mex$1,256 | 11/05/26 | ― | ||
| Mark Kong CFADBS | BuyReiteratedMex$688.76 | 09/28/26 | ― | ||
| Unknown AnalystDaiwaNot Ranked | BuyReiteratedMex$641.26 | 08/12/26 | ― | ||
| Unknown AnalystBOCOM International Holdings CompanyNot Ranked | BuyReiteratedMex$655.51 | 08/08/26 | ― | ||
| Unknown AnalystCLSANot Ranked | BuyReiteratedMex$764.05 | 08/06/26 | ― | ||
| David LiBank of America Securities | BuyReiteratedMex$579.03→Mex$606.65 | 08/06/26 | ― | ||
| Unknown AnalystUOB Kay HianNot Ranked | BuyReiteratedMex$629.38 | 08/06/26 | ― | ||
| Unknown AnalystNomuraNot Ranked | BuyReiteratedMex$643.02 | 07/24/26 | ― | ||
| Unknown AnalystMacquarieNot Ranked | BuyReiteratedMex$610.38 | 07/13/26 | ― | ||
| Unknown AnalystHSBCNot Ranked | BuyReiteratedMex$535.81 | 07/10/26 | ― | ||
| Unknown AnalystHuafu SecuritiesNot Ranked | BuyReiteratedMex$706.43 | 07/06/26 | ― | ||
| Unknown AnalystCitiNot Ranked | BuyReiteratedMex$645.53 | 06/02/26 | ― | ||
| Unknown AnalystCitic SecuritiesNot Ranked | BuyReiteratedMex$570.01→Mex$555.76 | 05/12/26 | ― | ||
| Unknown AnalystCMBC InternationalNot Ranked | BuyReiteratedMex$662.28 | 05/10/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering BeOne Medicines Ltd
3 Months
Success Rate1/4 ratings generated profit
25%
Average Return
+2.90%
Copying Tony Ren's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of +2.90% per trade.
1 Year
Success Rate4/4 ratings generated profit
100%
Average Return
+19.02%
Copying Tony Ren's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.02% per trade.
2 Years
Success Rate4/4 ratings generated profit
100%
Average Return
+42.95%
Copying Tony Ren's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.95% per trade.
6160N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 9 | 6 | 3 | 1 | 1 |
| Buy | 13 | 12 | 13 | 10 | 3 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 18 | 17 | 12 | 5 |
In the current month, 6160N has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 6160N average Analyst price target in the past 3 months is 870.84.
6160N Financial Forecast
HighMex$6.08
ConsensusMex$3.68
LowMex$2.36
6160N Earnings Forecast
Next quarter’s earnings estimate for 6160N is MXN 3.68 with a range of MXN 2.36 to MXN 6.08. The previous quarter’s EPS was MXN 4.65. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMex$36.3B
ConsensusMex$34.9B
LowMex$34.1B
6160N Sales Forecast
Next quarter’s sales forecast for 6160N is MXN 34.94B with a range of MXN 34.11B to MXN 36.27B. The previous quarter’s sales results were MXN 35.13B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
6160N Stock Forecast FAQ
What is MX:6160N’s average 12-month price target, according to analysts?
Based on analyst ratings, BeOne Medicines Ltd’s 12-month average price target is Mex$870.84.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BeOne Medicines Ltd a Buy, Sell or Hold?
BeOne Medicines Ltd has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is BeOne Medicines Ltd’s share price target?
The average share price target for BeOne Medicines Ltd is Mex$870.84. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$1,256.39, and the lowest forecast is Mex$667.38. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about BeOne Medicines Ltd?
BeOne Medicines Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of BeOne Medicines Ltd?
To buy shares of MX:6160N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
